Pharmacokinetics of fenbendazole following intravenous and oral administration to pigs

Mads Bjelke Petersen Department of Pharmacology and Pathobiology, Royal Veterinary and Agricultural University, 9 Ridebanevej, DK-1870 Frederiksberg C, Copenhagen, Denmark.
Present address is Scantox, 36A Hestehavevej, Ejby, DK-4623 Lille Skensved, Denmark.

Search for other papers by Mads Bjelke Petersen in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
and
Christian Friis Department of Pharmacology and Pathobiology, Royal Veterinary and Agricultural University, 9 Ridebanevej, DK-1870 Frederiksberg C, Copenhagen, Denmark.

Search for other papers by Christian Friis in
Current site
Google Scholar
PubMed
Close
 DVM, PhD

Abstract

Objective—To determine pharmacokinetics and metabolic patterns of fenbendazole after IV and oral administration to pigs.

Animals—4 mixed-breed female pigs weighing 32 to 45 kg.

Procedure—Fenbendazole was administered IV at a dose of 1 mg/kg. One week later, it was administered orally at a dose of 5 mg/kg. Blood samples were collected for up to 72 hours after administration, and plasma concentrations of fenbendazole, oxfendazole, and fenbendazole sulfone were determined by use of high-pressure liquid chromatography. Plasma pharmacokinetics were determined by use of noncompartmental methods.

Results—Body clearance of fenbendazole after IV administration was 1.36 L/h/kg, volume of distribution at steady state was 3.35 L/kg, and mean residence time was 2.63 hours. After oral administration, peak plasma concentration of fenbendazole was 0.07 µg/ml, time to peak plasma concentration was 3.75 hours, and mean residence time was 15.15 hours. Bioavailability of fenbendazole was 27.1%. Oxfendazole was the major plasma metabolite, accounting for two-thirds of the total area under the plasma concentration versus time curve after IV and oral administration. Fenbendazole accounted for 8.4% of the total AUC after IV administration and 4.5% after oral administration.

Conclusions and Clinical Relevance—Results indicate that fenbendazole was rapidly eliminated from plasma of pigs. The drug was rapidly absorbed after oral administration, but systemic bioavailability was low. ( Am J Vet Res 2000;61:573–576)

Abstract

Objective—To determine pharmacokinetics and metabolic patterns of fenbendazole after IV and oral administration to pigs.

Animals—4 mixed-breed female pigs weighing 32 to 45 kg.

Procedure—Fenbendazole was administered IV at a dose of 1 mg/kg. One week later, it was administered orally at a dose of 5 mg/kg. Blood samples were collected for up to 72 hours after administration, and plasma concentrations of fenbendazole, oxfendazole, and fenbendazole sulfone were determined by use of high-pressure liquid chromatography. Plasma pharmacokinetics were determined by use of noncompartmental methods.

Results—Body clearance of fenbendazole after IV administration was 1.36 L/h/kg, volume of distribution at steady state was 3.35 L/kg, and mean residence time was 2.63 hours. After oral administration, peak plasma concentration of fenbendazole was 0.07 µg/ml, time to peak plasma concentration was 3.75 hours, and mean residence time was 15.15 hours. Bioavailability of fenbendazole was 27.1%. Oxfendazole was the major plasma metabolite, accounting for two-thirds of the total area under the plasma concentration versus time curve after IV and oral administration. Fenbendazole accounted for 8.4% of the total AUC after IV administration and 4.5% after oral administration.

Conclusions and Clinical Relevance—Results indicate that fenbendazole was rapidly eliminated from plasma of pigs. The drug was rapidly absorbed after oral administration, but systemic bioavailability was low. ( Am J Vet Res 2000;61:573–576)

All Time Past Year Past 30 Days
Abstract Views 101 0 0
Full Text Views 1938 1572 615
PDF Downloads 657 298 30
Advertisement